rs727503108
|
|
A |
0.710 |
GeneticVariation |
CLINVAR |
The importance of evaluation of DNA amplificability in KRAS mutation testing with dideoxy sequencing using formalin-fixed and paraffin-embedded colorectal cancer tissues.
|
20926413 |
2011 |
rs104894364
|
|
A |
0.710 |
CausalMutation |
CLINVAR |
Prenatal detection of Noonan syndrome by mutation analysis of the PTPN11 and the KRAS genes.
|
20112233 |
2010 |
rs104894364
|
|
A |
0.710 |
CausalMutation |
CLINVAR |
Craniosynostosis in patients with Noonan syndrome caused by germline KRAS mutations.
|
19396835 |
2009 |
rs727503108
|
|
A |
0.710 |
GeneticVariation |
CLINVAR |
Craniosynostosis in patients with Noonan syndrome caused by germline KRAS mutations.
|
19396835 |
2009 |
rs104894364
|
|
A |
0.710 |
CausalMutation |
CLINVAR |
An activating KRAS mutation in imatinib-resistant chronic myeloid leukemia.
|
18509354 |
2008 |
rs104894364
|
|
A |
0.710 |
CausalMutation |
CLINVAR |
Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome.
|
17704260 |
2007 |
rs104894366
|
|
A |
0.710 |
CausalMutation |
CLINVAR |
We performed detailed biochemical and functional studies of three mutant K-Ras proteins (P34R, D153V, and F156L) found in individuals with Noonan syndrome and cardiofaciocutaneous syndrome.
|
17875937 |
2007 |
rs104894366
|
|
C |
0.710 |
GeneticVariation |
CLINVAR |
We performed detailed biochemical and functional studies of three mutant K-Ras proteins (P34R, D153V, and F156L) found in individuals with Noonan syndrome and cardiofaciocutaneous syndrome.
|
17875937 |
2007 |
rs104894366
|
|
A |
0.710 |
CausalMutation |
CLINVAR |
Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutations.
|
17056636 |
2007 |
rs104894364
|
|
A |
0.710 |
CausalMutation |
CLINVAR |
Germline mutations in components of the Ras signaling pathway in Noonan syndrome and related disorders.
|
16921267 |
2006 |
rs104894364
|
|
|
0.710 |
GeneticVariation |
BEFREE |
We discovered de novo germline KRAS mutations that introduce V14I, T58I or D153V amino acid substitutions in five individuals with Noonan syndrome and a P34R alteration in a individual with cardio-facio-cutaneous syndrome (MIM 115150), which has overlapping features with Noonan syndrome.
|
16474405 |
2006 |
rs104894364
|
|
A |
0.710 |
CausalMutation |
CLINVAR |
We discovered de novo germline KRAS mutations that introduce V14I, T58I or D153V amino acid substitutions in five individuals with Noonan syndrome and a P34R alteration in a individual with cardio-facio-cutaneous syndrome (MIM 115150), which has overlapping features with Noonan syndrome.
|
16474405 |
2006 |
rs104894366
|
|
A |
0.710 |
CausalMutation |
CLINVAR |
We discovered de novo germline KRAS mutations that introduce V14I, T58I or D153V amino acid substitutions in five individuals with Noonan syndrome and a P34R alteration in a individual with cardio-facio-cutaneous syndrome (MIM 115150), which has overlapping features with Noonan syndrome.
|
16474405 |
2006 |
rs104894366
|
|
|
0.710 |
GeneticVariation |
BEFREE |
We discovered de novo germline KRAS mutations that introduce V14I, T58I or D153V amino acid substitutions in five individuals with Noonan syndrome and a P34R alteration in a individual with cardio-facio-cutaneous syndrome (MIM 115150), which has overlapping features with Noonan syndrome.
|
16474405 |
2006 |
rs104894366
|
|
C |
0.710 |
GeneticVariation |
CLINVAR |
We discovered de novo germline KRAS mutations that introduce V14I, T58I or D153V amino acid substitutions in five individuals with Noonan syndrome and a P34R alteration in a individual with cardio-facio-cutaneous syndrome (MIM 115150), which has overlapping features with Noonan syndrome.
|
16474405 |
2006 |
rs727503108
|
|
A |
0.710 |
GeneticVariation |
CLINVAR |
Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome.
|
16474404 |
2006 |
rs104894366
|
|
C |
0.710 |
GeneticVariation |
CLINVAR |
Effector domain mutations dissociate p21ras effector function and GTPase-activating protein interaction.
|
8246952 |
1993 |
rs193929331
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Structure-energy-based predictions and network modelling of RASopathy and cancer missense mutations.
|
24803665 |
2014 |
rs193929331
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Tegumentary manifestations of Noonan and Noonan-related syndromes.
|
24037001 |
2013 |
rs193929331
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Multiple, diffuse schwannomas in a RASopathy phenotype patient with germline KRAS mutation: a causal relationship?
|
22211815 |
2012 |
rs727504662
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
KRAS gene mutations in Noonan syndrome familial cases cluster in the vicinity of the switch II region of the G-domain: report of another family with metopic craniosynostosis.
|
22488932 |
2012 |
rs104894359
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
Germline KRAS mutations cause aberrant biochemical and physical properties leading to developmental disorders.
|
20949621 |
2011 |
rs193929331
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Germline KRAS mutations cause aberrant biochemical and physical properties leading to developmental disorders.
|
20949621 |
2011 |
rs193929331
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Frequent pathway mutations of splicing machinery in myelodysplasia.
|
21909114 |
2011 |
rs727503110
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Germline KRAS mutations cause aberrant biochemical and physical properties leading to developmental disorders.
|
20949621 |
2011 |